✦ LIBER ✦

New fish oil derivative for preventing clinical relapses in Crohn's disease: A double blind placebo controlled randomized trial

Book ID: 122088695
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 181 KB
Volume: 108
Category: Article
ISSN: 0016-5085
DOI: 10.1016/0016-5085(95)27432-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etanercept for Active Crohn's Disease: A

Etanercept for Active Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

✍ William J. Sandborn; Stephen B. Hanauer; Seymour Katz; Michael Safdi; Douglas G. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Fish oil in psoriasis—a double-blind ran

Fish oil in psoriasis—a double-blind randomized placebo-controlled trial

✍ S.B. Bittiner; W.F.G. Tucker; S.S. Bleehen 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Prevention of relapse by mesalazine (Pen

Prevention of relapse by mesalazine (Pentasa®) in pediatric Crohn's disease: A multicenter, double-blind, randomized, placebo-controlled trial

✍ J.-P. Cezard; A. Munck; O. Mouterde; A. Morali; C. Lenaerts; A. Lachaux; D. Turc 📂 Article 📅 2009 🏛 Masson Editeur 🌐 French ⚖ 961 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease

✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des

Clinical trial: vitamin D3 treatment in

Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double-blind placebo-controlled study

✍ S. P. Jørgensen; J. Agnholt; H. Glerup; S. Lyhne; G. E. Villadsen; C. L. Hvas; L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Onercept for Moderate-to-Severe Crohn’s

Onercept for Moderate-to-Severe Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

✍ Rutgeerts, Paul; Sandborn, William J.; Fedorak, Richard N.; Rachmilewitz, Daniel 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 101 KB